US20150093462A1 - Watery Lotion Skin Care Compositions And Methods - Google Patents

Watery Lotion Skin Care Compositions And Methods Download PDF

Info

Publication number
US20150093462A1
US20150093462A1 US14/497,711 US201414497711A US2015093462A1 US 20150093462 A1 US20150093462 A1 US 20150093462A1 US 201414497711 A US201414497711 A US 201414497711A US 2015093462 A1 US2015093462 A1 US 2015093462A1
Authority
US
United States
Prior art keywords
extract
skin
fermentation
lactobacillus
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/497,711
Inventor
Daniel B. Yarosh
Thomas Mammone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ELC Management LLC
Original Assignee
ELC Management LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ELC Management LLC filed Critical ELC Management LLC
Priority to US14/497,711 priority Critical patent/US20150093462A1/en
Publication of US20150093462A1 publication Critical patent/US20150093462A1/en
Priority to US16/711,675 priority patent/US11369564B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/965Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of inanimate origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/007Preparations for dry skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/591Mixtures of compounds not provided for by any of the codes A61K2800/592 - A61K2800/596
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • A61K2800/5922At least two compounds being classified in the same subclass of A61K8/18
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/85Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88Two- or multipart kits
    • A61K2800/884Sequential application

Definitions

  • the invention is in the field of skin care compositions and regimens for treating skin, and more particularly, skin care compositions in the serum or watery lotion category and regimens for improving efficacy of individual products when they are layered onto the skin.
  • Watery lotions are very popular, particularly with Asian skin care consumers.
  • Watery lotions are generally considered to be lotions or serums with no, or a very insignificant oily phase. Most watery lotions contain water at greater than about 85%, or even greater than 90% by weight of the total composition. While the benefits of watery lotion include the light fresh feel of applying mostly water to skin, the disadvantage is that the high water content prevents inclusion of many skin benefit active ingredients that are compatible with, and can only be incorporated into compositions with a significant oil phase. Thus, the need gap is to formulate watery lotions having maximum effectiveness in treating skin while at the same time maintaining the high water content.
  • watery lotions are enhancing the effectiveness of watery lotions, not only through formulation, but using regimens where the watery lotion and one or more additional products are layered onto the skin to optimize efficacy without causing inhibitory activity. More specifically, the efficacy of watery lotions can be maximized by combining with skin care serums, especially those containing extracts from fermentation products of microorganisms such as Lactobacillus or Bifidobacterium.
  • watery lotions in providing skin benefits can be improved by layering of two or more products onto the skin, one of which is the watery lotion of the invention and the other being a skin care serum, cream, or lotion, preferably containing at least one extract from the fermentation of a microorganism from Lactobacillus or Bifidobacterium genus.
  • the invention is directed to a watery lotion composition for topical application to skin comprising an extract from the fermentation of a probiotic microorganism from Bifidobacterium or Lactobacillus genus and mineral water having at least 250 ppm of total mineral dissolved solids.
  • the invention is directed to a regimen for improving the efficacy of watery lotion and/or a second skin care product by layering onto the skin a watery lotion that contains an extract from the fermentation of a microorganism from the Bifidobacterium or Lactobacillus genus; and a second skin care product preferably also containing at least one extract from the fermentation of a probiotic microorganism from the Bifidobacterium or Lactobacillus genus.
  • the efficacies that may be improved include, but are not limited to, balanced cellular renewal, skin where the basal proliferative and epidermal differentiating layers are balanced to provide healthy, youthful skin, improved water retention, and as further set forth herein.
  • the invention is also directed to a skin surface comprised of a basal layer, an epidermal layer, a layer formed from application of a watery lotion composition containing at least one extract from the fermentation of a probiotic microorganisms from the Bifidobacterium or Lactobacillus genus; and a layer formed from application of a skin care product containing at least one extract from the fermentation of a probiotic microorganisms from the Bifidobacterium or Lactobacillus genus; wherein the compositions layered onto the skin cause the basal cells in the basal layer of the skin and the epidermal cells in the epidermal layer of the skin to exhibit balanced proliferative and differentiating activity respectively.
  • FIG. 1 depicts histological sections of skin stained with hematoxylin & eosin (H&E), Ki-67 protein and Caspase 3 using two separate antibodies. Ki-67 indicates proliferation and Caspase 3 indicates apoptosis.
  • the amount of basal cell proliferation and epidermal differentiation was shown in skin sections that are untreated, treated with a watery lotion, treated with a second skin care product alone, and treated with both products. The results show that skin sections treated with watery lotion and the second skin care product show balanced skin renewal where the new cell generation (or proliferation) in the basal layer and the cellular differentiation in the epidermal layer are balanced. Where cellular proliferation and differentiation in basal and epidermal layers is balanced, skin is most healthy, normalized and exhibits excellent integrity.
  • FIG. 2 depicts histological sections of untreated skin and skin treated with watery lotion alone, a skin care product (“Test Formula” or “TF”), and the combination of the watery lotion and the skin care product, stained to show cellular differentiation in the epidermal skin layer. Similar to the results in FIG. 1 , the sections treated with watery lotion and the second skin care product show balanced skin renewal.
  • Test Formula or “TF”
  • FIG. 3 depicts the increase in water content of skin treated with the combination of a watery lotion and a second skin care product when compared to skin treated with each product alone and untreated skin.
  • watery lotion means an aqueous based composition having from about 75-99% by weight of the total composition of water.
  • mineral water means water having at least 250 ppm of total mineral dissolved solids.
  • the watery lotion composition of the invention comprises at least about 80%, more preferably from about 80 to 99.9% by weight of water.
  • the water portion may comprise from 0.01 to 100%, preferably from 0.05 to 25%, more preferably from about 0.1 to 20% by weight of the total water portion, of mineral water having at least 250 ppm of total dissolved mineral solids.
  • the mineral water comprises concentrations of dissolved mineral solids including but not limited to aluminum, antimony, barium, beryllium, bismuth, boron, bromine, cadmium, calcium, carbon, cerium, cesium, chloride, chromium, cobalt, copper, dysprosium, erbium, europium, fluoride, gadolinium, gallium, germanium, gold, hafnium, homium, indium, iodine, iridium, iron, lanthanum, lithium, lutetium, magnesium manganese, molybdenum, neodymium, niobium, osmium, palladium, phosphorus, platinum, potassium, praseodymium, rhenium, rhodium, rubidium, ruthenium, samarium, scandium, selenium, silicon, silver, sodium, strontium, sulfur, tantalum, tellurium, terbium, thallium th
  • the mineral water has a pH ranging from 2.5 to 4.3, preferably from 2.6 to 3.9 and a specific gravity of 1.0 to 1.03.
  • a suitable mineral water may be purchased from TRC Nutritional Laboratories under the trade name 77LPPM TRC Minerals.
  • the watery lotion composition may comprise at least one extract, preferably in the form of a ferment or ferment lysate obtained by fermenting a microorganism from Lactobacillus .
  • Lactobacillus genus include, but are not limited to, plantarum, casei, crispatus , etc.
  • the ferment may be in the form of a lysate, filtrate, or both.
  • the fermentation product is lysed.
  • the fermentation product is filtered.
  • the ingredients may be purchased from Active Concepts under the tradename AC Probiotic 1; Natural F&P Co. Ltd under the tradename Lactobacillus crispatus KLB46; RNA Co. under the trade name K-LAC.
  • the ingredient may also be purchased in the form of mixtures with other ingredients or probiotic organisms.
  • the ferment may be present in amounts ranging from about 0.001 to 10%, preferably from about 0.1 to 5%, more preferably from about 0.1 to 3%.
  • the composition also comprises at least one extract, preferably in the form of a ferment or ferment lysate from the Bifidobacterium genus.
  • examples include Bifida ferment extract, Bifida ferment lysate, or Bifida ferment filtrate.
  • the fermentation extract of Bifida may also be in the form of mixtures with other ingredients or probiotic microorganisms.
  • the Bifidobacterium fermentation product may be present in the composition in amounts ranging from about 0.01 to 10%, preferably from about 0.05 to 5%, more preferably from about 0.1 to 2%.
  • the watery lotion may also contain other ingredients including botanically derived actives, peptides, humectants, surfactants, and preservatives.
  • acetylated peptides such as Acetyl hexapeptides followed by numbers ranging from 1 to 49 including all whole integers in between. Preferred is Acetyl hexapeptide-8 (sold under the tradename Argireline®).
  • palmitoylated peptides such as Palmitoyl oligopeptides, Palmitoyl pentapeptides, Palmitoyl hexapeptides, Palmitoyl tetrapeptides, Palmitoyl tripeptides.
  • Other suitable peptides are described in the C.T.F.A. International Cosmetic Ingredient Dictionary and Handbook, 11 th Edition, 2006. If present, the peptides may range from about 0.0001 to 3%, preferably from about 0.0005 to 2.5%, more preferably from about 0.001 to 1%.
  • the composition may also comprise one or more humectants. If present, they may range from 0.01 to 10%, preferably from 0.05 to 8%, more preferably from about 0.1 to 7%.
  • suitable humectants include glycols, sugars, and the like.
  • Suitable glycols are in monomeric or polymeric form and include polyethylene and polypropylene glycols such as PEG 4-200, which are polyethylene glycols having from 4 to 200 repeating ethylene oxide units; as well as C 1-6 alkylene glycols such as propylene glycol, butylene glycol, pentylene glycol, and the like.
  • Suitable sugars some of which are also polyhydric alcohols, are also suitable humectants.
  • sugars examples include glucose, fructose, honey, hydrogenated honey, inositol, maltose, mannitol, maltitol, sorbitol, sucrose, xylitol, xylose, polysachharides, and so on.
  • urea and/or hyaluronic acid are also suitable.
  • the humectants used in the composition of the invention are C 1-6 , preferably C 2-4 alkylene glycols, most particularly butylene glycol.
  • the composition may contain one or more surfactants.
  • Preferred are nonionic organic surfactants such as alkylene glycols, alkoxylated alcohols, or ethers, formed by the reaction of an alcohol with an alkylene oxide, usually ethylene or propylene oxide.
  • the alcohol is either a fatty alcohol having 6 to 30 carbon atoms.
  • alkylene glycols specifically ethylene or propylene glycols having from about 1 to 200 repeating EO or PO units, including all whole integers from 1 to 200. More preferred are polyethylene glycols (PEG) having from 2 to 100 repeating units, for example PEG 1-200 including all whole integers in between. More specifically are PEG where the number of repeating ethylene oxide units ranges from 40-75. Specific examples include PEG-60, PEG-75 is preferred.
  • Steareth 2-100 which is formed by the reaction of stearyl alcohol and ethylene oxide and the number of ethylene oxide units ranges from 2 to 100 including all whole integers in between; Oleth 2-100, which is formed by the reaction of oleyl alcohol and ethylene oxide; Beheneth 5-30 which is formed by the reaction of behenyl alcohol and ethylene oxide where the number of repeating ethylene oxide units is 5 to 30; Ceteareth 2-100, formed by the reaction of a mixture of cetyl and stearyl alcohol with ethylene oxide, where the number of repeating ethylene oxide units in the molecule is 2 to 100; Ceteth 1-45 which is formed by the reaction of cetyl alcohol and ethylene oxide, and the number of repeating ethylene oxide units is 1 to 45, and so on.
  • polyethylene glycols of glycerin or glucose such as Glycereth 2-100, gluceth 2-100 including all whole integers in between.
  • Suitable nonionic surfactants include alkoxylated sorbitan and alkoxylated sorbitan derivatives.
  • alkoxylation, in particular ethoxylation of sorbitan provides polyalkoxylated sorbitan derivatives.
  • Esterification of polyalkoxylated sorbitan provides sorbitan esters such as the polysorbates.
  • the polyalkyoxylated sorbitan can be esterified with C6-30, preferably C12-22 fatty acids. Examples of such ingredients include Polysorbates 20-85, sorbitan oleate, sorbitan sesquioleate, sorbitan palmitate, sorbitan sesquiisostearate, sorbitan stearate, and so on.
  • Such surfactants may be present in amounts ranging from about 0.01 to 25%, preferably from about 0.05 to 20%, more preferably from about 0.1 to 15% by weight of the total composition.
  • the composition may also contain one or more ingredients that increase the viscosity of the composition. If present, ranges are from about 0.01 to 10%, preferably from about 0.05 to 8%, more preferably from about 0.1 to 5% by weight of the total composition.
  • examples include synthetic polymeric thickening agents such as carbopol, C10-30 alkyl acrylates crosspolymer, acrylates copolymer, and ammonium acryloyldimethyltaurate/beheneth-25 copolymer, sodium acryloyldimethyl taurate/VP copolymer, ammonium acryloyldimethyltaurate copolymer and those sold by Clariant under the Aristoflex® trademark.
  • Suitable botanical extracts include extracts from plants (herbs, roots, flowers, fruits, seeds) such as flowers, fruits, vegetables, and so on, including yeast ferment extract, Padina Pavonica extract, thermus thermophilis ferment extract, camelina sativa seed oil, Boswellia serrata extract, olive extract, Arabidopsis thaliana extract, Acacia dealbata extract, Acer saccharinum (sugar maple), acidopholus, acorns, aesculus, agaricus, agave, agrimonia, algae, aloe, citrus, brassica, cinnamon, orange, apple, blueberry, cranberry, peach, pear, lemon, lime, pea, seaweed, caffeine, green tea, chamomile, willowbark, mul
  • Glycyrrhiza glabra Salix nigra, Macrocycstis pyrifera, Pyrus malus, Saxifraga sarmentosa, Vitis vinifera, Morus nigra, Scutellaria baicalensis, Anthemis nobilis, Salvia sclarea, Rosmarinus officianalis, Citrus medica limonum, Panax ginseng, Siegesbeckia orientalis, Fructus mume, Ascophyllum nodosum, Bifida Ferment lysate, Glycine soja extract, Beta vulgaris, Haberlea rhodopensis, Polygonum cuspidatum, Citrus aurantium dulcis, Vitis vinifera, Selaginella tamariscina, Humulus lupulus, Citrus reticulata peel, Punica granatum, Asparagopsis armata, Curcuma longa
  • the invention is directed to a regimen for improving the efficacy of watery lotion and/or a second skin care product also applied to skin.
  • the watery lotion contains an extract from the fermentation of a probiotic microorganism from the Bifidobacterium or Lactobacillus genus; and a second skin care product may also containing at least one extract from the fermentation of a probiotic microorganism from the Bifidobacterium or Lactobacillus genus.
  • the efficacy that is improved includes balanced skin renewal between basal and epidermal skin layers (where cellular proliferation in the basal layer and cellular differentiation in the epidermal layer are balanced), improved skin integrity, improved skin barrier properties, improving overall skin health, normalizing skin, and improving moisturization by causing increased water retention in skin.
  • the balanced skin renewal causes a proliferation to differentiation ratio in the basal to epidermal layers of skin that ranges from about 30-70% proliferation and 30-70% differentiation. More preferred is where the proliferation to differentiation ratio in the basal to epidermal layers ranges from 40-60% proliferation to 60-40% differentiation. Most preferred is where the proliferation to differentiation ratio in the basal to epidermal layers of skin is about 50% proliferation and about 50% differentiation. This provides optimal skin integrity, healthy and viability.
  • treatment according to the regiment of the invention will cause improved proliferative activity and ensure that the proliferative activity is balanced with cellular differentiation in the epidermal layer to most closely approximate the health and viability of youthful skin.
  • the second skin care product may be in the form of a cream, lotion, or serum.
  • the second skin care product is in the form of a serum comprising from about 20-99% water, and from about 0.1-20% one or more surfactants, and optionally, about 0.1-20% of one or more oils, and optionally 0.1-10% of one or more peptides, botanical extracts, viscosity modifiers, humectants, etc. as set forth above with respect to the watery lotion.
  • the serum comprises, from about 20-99% water, 0.1-10% surfactants, 0.1-5% oil, 0.1-3% extract from probiotic microorganism, preferably Bifidobacterium; 0.1-10% of one or more humectants.
  • the skin care product is in the form of a serum comprising:
  • one or more surfactants selected from alkylene glycols such as ethylene or propylene glycols; alkoxylated glucose, alkoxylated alcohols, glyceryl esters; glyceryl ethers, or mixtures thereof,
  • humectants selected from polyhydric alcohols, alkylene glycols or glycerin, butylene glycol, hexylene glycol, or mixtures thereof,
  • the skin care product comprises:
  • one or more surfactants selected from polyethylene glycols having from 40-100 repeat ethylene oxide units; polypropylene glycols having from 3 to 100 repeat propylene glycol units; polyethylene/polypropylene glycols having from about 40-100 repeat ethylene glycol units and 3-100 repeat propylene glycol units; C 12-40 straight or branched chain, saturated or unsaturated alkoxylated alcohols; polyethylene glycols of glycerin; polyethylene glycols of glucose or methyl glucose; polyethylene glycols of cholesterol; glyceryl esters; glyceryl ethers; or mixtures thereof.
  • humectants selected from polyhydric alcohols, alkylene glycols or glycerin, butylene glycol, hexylene glycol, propanediol, or mixtures thereof.
  • the skin care product comprises:
  • one or more surfactants selected from PEG-60, PEG-75, PPG-5-Ceteth-20, Methyl gluceth-20, Bis-PEG-18 methyl ether dimethyl silane, Glycereth-26, Oleth-3 phosphate, Oleth-3, Oleth-5, Choleth-24, Ceteth-24, PEG-20 methyl glucosesesquiisostearate, and mixtures thereof;
  • humectants selected from polyhydric alcohols, alkylene glycols or glycerin, butylene glycol, hexylene glycol, propanediol, or mixtures thereof.
  • the products may be applied in either order.
  • the watery lotion may be applied first, followed by application of the second skin care product or vice versa.
  • the products both improve the efficacy of each other, such that the efficacy of the watery lotion is improved when combined with the other skin care product, and the other skin care product efficacy is improved when combined with the watery lotion.
  • the efficacies that may be improved include increased water retention in skin.
  • a watery lotion formula was prepared as follows:
  • composition was prepared by combining the ingredients and mixing well to emulsify.
  • Example 1 The watery lotion of Example 1 was tested along with a commercially available skin serum formula (“Test Formula” or “TF”) with the ingredient labeling on the product as set forth below:
  • EFT-300 skin models were dispensed into 6 well plates and maintained in incubator at 37° C. Daily for 48 hours wells were treated with 5 ml EFT-300 Media (Mattek) and (1) 20 uL of Test Formula (“TF”); or (2) 20 uL of watery lotion of Example 1; or (3) 20 uL of watery lotion applied for 1 hour followed by application of 20 uL of Test Formula; or (4) Untreated control.
  • TF Test Formula
  • Skins were fixed in 5% formalin for 24 hours at 4° C., embedded in paraffin and sectioned at 5 uM. Sections were stained with hematoxylin & eosin (H&E) stain to highlight overall morphology. In addition, other sections were treated with green (anti-Ki67) stain and red (anti-caspase 3) stain from Biocare Medical to identify proliferating or apoptotic cells respectively.
  • Antibodies for filaggrin, involucrin, and transglutaminase were purchased from Abcam® sections were exposed to antibodies to quantify the degree of cellular differentiation in the histological sections. Photographic images were taken at 40 ⁇ . Scale bars are 0.05 mm. The results are set forth in FIG. 1 .
  • the untreated control H&E and Ki-67 Caspase stained sections shows a basal to epidermal ratio of about 50:50.
  • the basal skin layer shows cellular proliferation.
  • the upper, epidermal layer is somewhat disrupted, but shows that cellular differentiation has occurred.
  • Skin sections treated with Test Formula show an increased basal layer that indicates that such treatment caused increased cellular proliferation in the basal layer.
  • the epidermal layer is decreased in thickness compared to the untreated control, showing that the Test Formula appears to have somewhat of an inhibitory effect on the epidermal, differentiating, skin layer.
  • FIG. 2 shows skin sections marked for the presence of filaggrin, which is another marker for cellular differentiation.
  • the skin section showing untreated control demonstrates a differentiated, but somewhat disrupted epidermal layer.
  • Test Formula shows that the application of the Test Formula reduces the differentiated layer in the skin, thus apparently having a slightly inhibitory effect on cellular differentiation.
  • the skin section “WL” shows an increased epidermal layer demonstrating that the watery lotion does increase cellular differentiation in the basal layer.
  • Test Formula+WL shows that the sequential or combined application of Test Formula and WL shows more than an additive effect in increasing cellular differentiation in the epidermal layer in spite of the fact that one of the products (Test Formula) is shown to have an inhibitory effect on cellular differentiation in the basal layer.
  • composition and method of the invention was further tested to demonstrate increased water retention in skin using the product combination of the invention.
  • EFT-300 skin models were treated apically with samples alone or layered at day 0 and basal with 3 ml Media in a 6 well plate and incubated at 37° C. Samples were untreated control, Test Formula from Example 2 and Watery lotion formula of Example 1 (“WL”).

Abstract

A watery lotion composition for topical application to skin comprising at least one extract from the fermentation of the microorganism Bifidobacterium, at least one extract from the fermentation of the microorganism Lactobacillus, and mineral water having at least 250 ppm of total mineral dissolved solids and a method for improving the efficacy of a watery lotion and/or a second skin care product by layering the products on the skin.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • The present application claims priority from U.S. Provisional Application No. 61/884,599, filed Sep. 30, 2013.
  • TECHNICAL FIELD
  • The invention is in the field of skin care compositions and regimens for treating skin, and more particularly, skin care compositions in the serum or watery lotion category and regimens for improving efficacy of individual products when they are layered onto the skin.
  • BACKGROUND OF THE INVENTION
  • Skin care products referred to as watery lotions are very popular, particularly with Asian skin care consumers. Watery lotions are generally considered to be lotions or serums with no, or a very insignificant oily phase. Most watery lotions contain water at greater than about 85%, or even greater than 90% by weight of the total composition. While the benefits of watery lotion include the light fresh feel of applying mostly water to skin, the disadvantage is that the high water content prevents inclusion of many skin benefit active ingredients that are compatible with, and can only be incorporated into compositions with a significant oil phase. Thus, the need gap is to formulate watery lotions having maximum effectiveness in treating skin while at the same time maintaining the high water content.
  • Also of interest is enhancing the effectiveness of watery lotions, not only through formulation, but using regimens where the watery lotion and one or more additional products are layered onto the skin to optimize efficacy without causing inhibitory activity. More specifically, the efficacy of watery lotions can be maximized by combining with skin care serums, especially those containing extracts from fermentation products of microorganisms such as Lactobacillus or Bifidobacterium.
  • It has been discovered that formulating watery lotions with a certain combination of ferments and mineral containing water with mineral concentrations greater than what is found in de-ionized water and, in some cases, similar to what is found in blood, provides compositions with maximum effectiveness.
  • In addition, it has been discovered that the efficacy of watery lotions in providing skin benefits can be improved by layering of two or more products onto the skin, one of which is the watery lotion of the invention and the other being a skin care serum, cream, or lotion, preferably containing at least one extract from the fermentation of a microorganism from Lactobacillus or Bifidobacterium genus.
  • SUMMARY OF THE INVENTION
  • The invention is directed to a watery lotion composition for topical application to skin comprising an extract from the fermentation of a probiotic microorganism from Bifidobacterium or Lactobacillus genus and mineral water having at least 250 ppm of total mineral dissolved solids.
  • The invention is directed to a regimen for improving the efficacy of watery lotion and/or a second skin care product by layering onto the skin a watery lotion that contains an extract from the fermentation of a microorganism from the Bifidobacterium or Lactobacillus genus; and a second skin care product preferably also containing at least one extract from the fermentation of a probiotic microorganism from the Bifidobacterium or Lactobacillus genus. The efficacies that may be improved include, but are not limited to, balanced cellular renewal, skin where the basal proliferative and epidermal differentiating layers are balanced to provide healthy, youthful skin, improved water retention, and as further set forth herein.
  • The invention is also directed to a skin surface comprised of a basal layer, an epidermal layer, a layer formed from application of a watery lotion composition containing at least one extract from the fermentation of a probiotic microorganisms from the Bifidobacterium or Lactobacillus genus; and a layer formed from application of a skin care product containing at least one extract from the fermentation of a probiotic microorganisms from the Bifidobacterium or Lactobacillus genus; wherein the compositions layered onto the skin cause the basal cells in the basal layer of the skin and the epidermal cells in the epidermal layer of the skin to exhibit balanced proliferative and differentiating activity respectively.
  • DESCRIPTION OF THE DRAWINGS
  • FIG. 1: depicts histological sections of skin stained with hematoxylin & eosin (H&E), Ki-67 protein and Caspase 3 using two separate antibodies. Ki-67 indicates proliferation and Caspase 3 indicates apoptosis. The amount of basal cell proliferation and epidermal differentiation was shown in skin sections that are untreated, treated with a watery lotion, treated with a second skin care product alone, and treated with both products. The results show that skin sections treated with watery lotion and the second skin care product show balanced skin renewal where the new cell generation (or proliferation) in the basal layer and the cellular differentiation in the epidermal layer are balanced. Where cellular proliferation and differentiation in basal and epidermal layers is balanced, skin is most healthy, normalized and exhibits excellent integrity.
  • FIG. 2: depicts histological sections of untreated skin and skin treated with watery lotion alone, a skin care product (“Test Formula” or “TF”), and the combination of the watery lotion and the skin care product, stained to show cellular differentiation in the epidermal skin layer. Similar to the results in FIG. 1, the sections treated with watery lotion and the second skin care product show balanced skin renewal.
  • FIG. 3: depicts the increase in water content of skin treated with the combination of a watery lotion and a second skin care product when compared to skin treated with each product alone and untreated skin.
  • DETAILED DESCRIPTION
  • All percentages mentioned herein are percentages by weight unless otherwise indicated.
  • The term “watery lotion” means an aqueous based composition having from about 75-99% by weight of the total composition of water.
  • The term “mineral water” means water having at least 250 ppm of total mineral dissolved solids.
  • I. The Watery Lotion Composition
  • A. Mineral Water
  • The watery lotion composition of the invention comprises at least about 80%, more preferably from about 80 to 99.9% by weight of water. The water portion may comprise from 0.01 to 100%, preferably from 0.05 to 25%, more preferably from about 0.1 to 20% by weight of the total water portion, of mineral water having at least 250 ppm of total dissolved mineral solids. In one preferred embodiment the mineral water comprises concentrations of dissolved mineral solids including but not limited to aluminum, antimony, barium, beryllium, bismuth, boron, bromine, cadmium, calcium, carbon, cerium, cesium, chloride, chromium, cobalt, copper, dysprosium, erbium, europium, fluoride, gadolinium, gallium, germanium, gold, hafnium, homium, indium, iodine, iridium, iron, lanthanum, lithium, lutetium, magnesium manganese, molybdenum, neodymium, niobium, osmium, palladium, phosphorus, platinum, potassium, praseodymium, rhenium, rhodium, rubidium, ruthenium, samarium, scandium, selenium, silicon, silver, sodium, strontium, sulfur, tantalum, tellurium, terbium, thallium thordium, thulium, tin, titanium, tungsten, vanadium, ytterbium, yttrium, zinc, zirconium. In another preferred embodiment, the mineral water has a pH ranging from 2.5 to 4.3, preferably from 2.6 to 3.9 and a specific gravity of 1.0 to 1.03. A suitable mineral water may be purchased from TRC Nutritional Laboratories under the trade name 77LPPM TRC Minerals.
  • B. Extract from Probiotic Microorganism
  • 1. Extract from Lactobacillus Genus
  • The watery lotion composition may comprise at least one extract, preferably in the form of a ferment or ferment lysate obtained by fermenting a microorganism from Lactobacillus. Examples of the Lactobacillus genus include, but are not limited to, plantarum, casei, crispatus, etc. The ferment may be in the form of a lysate, filtrate, or both. In the case of a lysate, the fermentation product is lysed. In the case of a filtrate, the fermentation product is filtered. The ingredients may be purchased from Active Concepts under the tradename AC Probiotic 1; Natural F&P Co. Ltd under the tradename Lactobacillus crispatus KLB46; RNA Co. under the trade name K-LAC. The ingredient may also be purchased in the form of mixtures with other ingredients or probiotic organisms.
  • The ferment may be present in amounts ranging from about 0.001 to 10%, preferably from about 0.1 to 5%, more preferably from about 0.1 to 3%.
  • 2. Extract from Bifidobacterium Genus
  • The composition also comprises at least one extract, preferably in the form of a ferment or ferment lysate from the Bifidobacterium genus. Examples include Bifida ferment extract, Bifida ferment lysate, or Bifida ferment filtrate. The fermentation extract of Bifida may also be in the form of mixtures with other ingredients or probiotic microorganisms. The Bifidobacterium fermentation product may be present in the composition in amounts ranging from about 0.01 to 10%, preferably from about 0.05 to 5%, more preferably from about 0.1 to 2%.
  • C. Other Ingredients
  • The watery lotion may also contain other ingredients including botanically derived actives, peptides, humectants, surfactants, and preservatives.
  • 1. Peptides
  • Examples of suitable peptides including those having beneficial effects on skin are acetylated peptides, such as Acetyl hexapeptides followed by numbers ranging from 1 to 49 including all whole integers in between. Preferred is Acetyl hexapeptide-8 (sold under the tradename Argireline®). Also suitable are palmitoylated peptides such as Palmitoyl oligopeptides, Palmitoyl pentapeptides, Palmitoyl hexapeptides, Palmitoyl tetrapeptides, Palmitoyl tripeptides. Other suitable peptides are described in the C.T.F.A. International Cosmetic Ingredient Dictionary and Handbook, 11th Edition, 2006. If present, the peptides may range from about 0.0001 to 3%, preferably from about 0.0005 to 2.5%, more preferably from about 0.001 to 1%.
  • 2. Humectants
  • The composition may also comprise one or more humectants. If present, they may range from 0.01 to 10%, preferably from 0.05 to 8%, more preferably from about 0.1 to 7%. Examples of suitable humectants include glycols, sugars, and the like. Suitable glycols are in monomeric or polymeric form and include polyethylene and polypropylene glycols such as PEG 4-200, which are polyethylene glycols having from 4 to 200 repeating ethylene oxide units; as well as C1-6 alkylene glycols such as propylene glycol, butylene glycol, pentylene glycol, and the like. Suitable sugars, some of which are also polyhydric alcohols, are also suitable humectants. Examples of such sugars include glucose, fructose, honey, hydrogenated honey, inositol, maltose, mannitol, maltitol, sorbitol, sucrose, xylitol, xylose, polysachharides, and so on. Also suitable are urea and/or hyaluronic acid. Preferably, the humectants used in the composition of the invention are C1-6, preferably C2-4 alkylene glycols, most particularly butylene glycol.
  • 3. Surfactants
  • The composition may contain one or more surfactants. Preferred are nonionic organic surfactants such as alkylene glycols, alkoxylated alcohols, or ethers, formed by the reaction of an alcohol with an alkylene oxide, usually ethylene or propylene oxide. Preferably the alcohol is either a fatty alcohol having 6 to 30 carbon atoms.
  • Examples of alkylene glycols, specifically ethylene or propylene glycols having from about 1 to 200 repeating EO or PO units, including all whole integers from 1 to 200. More preferred are polyethylene glycols (PEG) having from 2 to 100 repeating units, for example PEG 1-200 including all whole integers in between. More specifically are PEG where the number of repeating ethylene oxide units ranges from 40-75. Specific examples include PEG-60, PEG-75 is preferred.
  • Examples of such ingredients include Steareth 2-100, which is formed by the reaction of stearyl alcohol and ethylene oxide and the number of ethylene oxide units ranges from 2 to 100 including all whole integers in between; Oleth 2-100, which is formed by the reaction of oleyl alcohol and ethylene oxide; Beheneth 5-30 which is formed by the reaction of behenyl alcohol and ethylene oxide where the number of repeating ethylene oxide units is 5 to 30; Ceteareth 2-100, formed by the reaction of a mixture of cetyl and stearyl alcohol with ethylene oxide, where the number of repeating ethylene oxide units in the molecule is 2 to 100; Ceteth 1-45 which is formed by the reaction of cetyl alcohol and ethylene oxide, and the number of repeating ethylene oxide units is 1 to 45, and so on.
  • Also suitable are polyethylene glycols of glycerin or glucose such as Glycereth 2-100, gluceth 2-100 including all whole integers in between.
  • Other suitable nonionic surfactants include alkoxylated sorbitan and alkoxylated sorbitan derivatives. For example, alkoxylation, in particular ethoxylation of sorbitan provides polyalkoxylated sorbitan derivatives. Esterification of polyalkoxylated sorbitan provides sorbitan esters such as the polysorbates. For example, the polyalkyoxylated sorbitan can be esterified with C6-30, preferably C12-22 fatty acids. Examples of such ingredients include Polysorbates 20-85, sorbitan oleate, sorbitan sesquioleate, sorbitan palmitate, sorbitan sesquiisostearate, sorbitan stearate, and so on.
  • Also suitable are various types of betaine surfactants. Such surfactants may be present in amounts ranging from about 0.01 to 25%, preferably from about 0.05 to 20%, more preferably from about 0.1 to 15% by weight of the total composition.
  • 4. Viscosity Modifiers
  • The composition may also contain one or more ingredients that increase the viscosity of the composition. If present, ranges are from about 0.01 to 10%, preferably from about 0.05 to 8%, more preferably from about 0.1 to 5% by weight of the total composition. Examples include synthetic polymeric thickening agents such as carbopol, C10-30 alkyl acrylates crosspolymer, acrylates copolymer, and ammonium acryloyldimethyltaurate/beheneth-25 copolymer, sodium acryloyldimethyl taurate/VP copolymer, ammonium acryloyldimethyltaurate copolymer and those sold by Clariant under the Aristoflex® trademark.
  • 5. Botanical Extracts
  • It may be desirable to include one or more botanical extracts in the compositions. If so, suggested ranges are from about 0.0001 to 10%, preferably about 0.0005 to 8%, more preferably about 0.001 to 5% by weight of the total composition. Suitable botanical extracts include extracts from plants (herbs, roots, flowers, fruits, seeds) such as flowers, fruits, vegetables, and so on, including yeast ferment extract, Padina Pavonica extract, thermus thermophilis ferment extract, camelina sativa seed oil, Boswellia serrata extract, olive extract, Arabidopsis thaliana extract, Acacia dealbata extract, Acer saccharinum (sugar maple), acidopholus, acorns, aesculus, agaricus, agave, agrimonia, algae, aloe, citrus, brassica, cinnamon, orange, apple, blueberry, cranberry, peach, pear, lemon, lime, pea, seaweed, caffeine, green tea, chamomile, willowbark, mulberry, poppy, and those set forth on pages 1646 through 1660 of the CTFA Cosmetic Ingredient Handbook, Eighth Edition, Volume 2. Further specific examples include, but are not limited to, Glycyrrhiza glabra, Salix nigra, Macrocycstis pyrifera, Pyrus malus, Saxifraga sarmentosa, Vitis vinifera, Morus nigra, Scutellaria baicalensis, Anthemis nobilis, Salvia sclarea, Rosmarinus officianalis, Citrus medica limonum, Panax ginseng, Siegesbeckia orientalis, Fructus mume, Ascophyllum nodosum, Bifida Ferment lysate, Glycine soja extract, Beta vulgaris, Haberlea rhodopensis, Polygonum cuspidatum, Citrus aurantium dulcis, Vitis vinifera, Selaginella tamariscina, Humulus lupulus, Citrus reticulata peel, Punica granatum, Asparagopsis armata, Curcuma longa, Menyanthes trifoliata, Helianthus annuus, Hordeum vulgare, Cucumis sativus, Evernia prunastri, Evernia furfuracea, and mixtures thereof.
  • II. The Method
  • The invention is directed to a regimen for improving the efficacy of watery lotion and/or a second skin care product also applied to skin. More specifically, the watery lotion contains an extract from the fermentation of a probiotic microorganism from the Bifidobacterium or Lactobacillus genus; and a second skin care product may also containing at least one extract from the fermentation of a probiotic microorganism from the Bifidobacterium or Lactobacillus genus.
  • The efficacy that is improved includes balanced skin renewal between basal and epidermal skin layers (where cellular proliferation in the basal layer and cellular differentiation in the epidermal layer are balanced), improved skin integrity, improved skin barrier properties, improving overall skin health, normalizing skin, and improving moisturization by causing increased water retention in skin. Preferably, the balanced skin renewal causes a proliferation to differentiation ratio in the basal to epidermal layers of skin that ranges from about 30-70% proliferation and 30-70% differentiation. More preferred is where the proliferation to differentiation ratio in the basal to epidermal layers ranges from 40-60% proliferation to 60-40% differentiation. Most preferred is where the proliferation to differentiation ratio in the basal to epidermal layers of skin is about 50% proliferation and about 50% differentiation. This provides optimal skin integrity, healthy and viability. In addition, since the proliferative activity of cells in the basal layer decreases with age, treatment according to the regiment of the invention will cause improved proliferative activity and ensure that the proliferative activity is balanced with cellular differentiation in the epidermal layer to most closely approximate the health and viability of youthful skin.
  • The second skin care product may be in the form of a cream, lotion, or serum. In one preferred embodiment the second skin care product is in the form of a serum comprising from about 20-99% water, and from about 0.1-20% one or more surfactants, and optionally, about 0.1-20% of one or more oils, and optionally 0.1-10% of one or more peptides, botanical extracts, viscosity modifiers, humectants, etc. as set forth above with respect to the watery lotion. Preferred is where the serum comprises, from about 20-99% water, 0.1-10% surfactants, 0.1-5% oil, 0.1-3% extract from probiotic microorganism, preferably Bifidobacterium; 0.1-10% of one or more humectants. More preferred is where the skin care product is in the form of a serum comprising:
  • 20-99% water,
  • 0.1-5% one or more surfactants selected from alkylene glycols such as ethylene or propylene glycols; alkoxylated glucose, alkoxylated alcohols, glyceryl esters; glyceryl ethers, or mixtures thereof,
  • 0.1-3% extract from probiotic microorganisms selected from Lactobacillus genus, Bifidobacterium genus, or mixtures thereof,
  • 0.1-10% of humectants selected from polyhydric alcohols, alkylene glycols or glycerin, butylene glycol, hexylene glycol, or mixtures thereof,
  • More preferred is where the skin care product comprises:
  • 20-99% water,
  • 0.1-5% one or more surfactants selected from polyethylene glycols having from 40-100 repeat ethylene oxide units; polypropylene glycols having from 3 to 100 repeat propylene glycol units; polyethylene/polypropylene glycols having from about 40-100 repeat ethylene glycol units and 3-100 repeat propylene glycol units; C12-40 straight or branched chain, saturated or unsaturated alkoxylated alcohols; polyethylene glycols of glycerin; polyethylene glycols of glucose or methyl glucose; polyethylene glycols of cholesterol; glyceryl esters; glyceryl ethers; or mixtures thereof.
  • 0.1-3% extract from probiotic microorganisms selected from Lactobacillus genus, Bifidobacterium genus, or mixtures thereof,
  • 0.1-10% of humectants selected from polyhydric alcohols, alkylene glycols or glycerin, butylene glycol, hexylene glycol, propanediol, or mixtures thereof.
  • Even more preferred is where the skin care product comprises:
  • 20-99% water,
  • 0.1-5% one or more surfactants selected from PEG-60, PEG-75, PPG-5-Ceteth-20, Methyl gluceth-20, Bis-PEG-18 methyl ether dimethyl silane, Glycereth-26, Oleth-3 phosphate, Oleth-3, Oleth-5, Choleth-24, Ceteth-24, PEG-20 methyl glucosesesquiisostearate, and mixtures thereof;
  • 0.1-3% extract from probiotic microorganisms selected from Lactobacillus genus, Bifidobacterium genus in the form of a ferment or ferment lysate, or mixtures thereof,
  • 0.1-10% of humectants selected from polyhydric alcohols, alkylene glycols or glycerin, butylene glycol, hexylene glycol, propanediol, or mixtures thereof.
  • In the method of the invention, the products may be applied in either order. Specifically, the watery lotion may be applied first, followed by application of the second skin care product or vice versa. The products both improve the efficacy of each other, such that the efficacy of the watery lotion is improved when combined with the other skin care product, and the other skin care product efficacy is improved when combined with the watery lotion. The efficacies that may be improved include increased water retention in skin.
  • The invention will be further described in connection with the following examples which are set forth for the purposes of illustration only.
  • Example 1
  • A watery lotion formula was prepared as follows:
  • % by
    Ingredient weight
    Water QS100
    Caffeine 0.05
    Betaine (surfactant) 1.00
    Trehalose (viscosity modifier) 0.50
    Carbopol (viscosity modifier) 7.00
    Tromethane 0.13
    PEG-75 (surfactant) 3.00
    Bifida ferment lysate 5.00
    Acetyl glucosamine 0.50
    Lactobacillus ferment 1.00
    Spring (mineral) water (TRC Nutritional Laboratories- 0.10
    77LPPM TRC Minerals)
    Acetyl hexpeptide-8 (peptide) 0.10
    Butylene glycol (humectants) 0.50
    Hyaluronic acid (humectant) 0.05
    Pentylene glycol (humectant) 1.00
    Propanediol (humectant) 2.00
    Anthemis nobilis (Chamomile) extract (botanical extract) 0.002
    PPG-5-Ceteth-20 (non-ionic surfactant) 0.12
    Butylene glycol (humectants) 1.00
  • The composition was prepared by combining the ingredients and mixing well to emulsify.
  • Example 2
  • The watery lotion of Example 1 was tested along with a commercially available skin serum formula (“Test Formula” or “TF”) with the ingredient labeling on the product as set forth below:
  • WATER\AQUA\EAU; BIFIDA FERMENT LYSATE; METHYL GLUCETH-20; PEG-75; BIS-PEG-18 METHYL ETHER DIMETHYL SILANE; BUTYLENE GLYCOL; PROPANEDIOL; COLA ACUMINATA (KOLA) SEED EXTRACT; ECHINACEA PURPUREA (CONEFLOWER) EXTRACT; ANTHEMIS NOBILIS (CHAMOMILE); HYDROLYZED ALGIN; PANTETHINE; CAFFEINE; LECITHIN; ETHYLHEXYLGLYCERIN; SODIUM RNA; BISABOLOL; GLYCERETH-26; SQUALANE; SODIUM HYALURONATE; OLETH-3 PHOSPHATE; CAPRYLYL GLYCOL; LACTOBACILLUS FERMENT; OLETH-3; OLETH-5; YEAST EXTRACT\FAEX\EXTRAIT DE LEVURE; CHOLETH-24; HYDROGENATED LECITHIN; CETETH-24; TOCOPHERYL ACETATE; ETHYLHEXYL METHOXYCINNAMATE; HEXYLENE GLYCOL; CARBOMER.
  • EFT (Epidermal Full Thickness)-300 skin models were dispensed into 6 well plates and maintained in incubator at 37° C. Daily for 48 hours wells were treated with 5 ml EFT-300 Media (Mattek) and (1) 20 uL of Test Formula (“TF”); or (2) 20 uL of watery lotion of Example 1; or (3) 20 uL of watery lotion applied for 1 hour followed by application of 20 uL of Test Formula; or (4) Untreated control.
  • Skins were fixed in 5% formalin for 24 hours at 4° C., embedded in paraffin and sectioned at 5 uM. Sections were stained with hematoxylin & eosin (H&E) stain to highlight overall morphology. In addition, other sections were treated with green (anti-Ki67) stain and red (anti-caspase 3) stain from Biocare Medical to identify proliferating or apoptotic cells respectively. Antibodies for filaggrin, involucrin, and transglutaminase were purchased from Abcam® sections were exposed to antibodies to quantify the degree of cellular differentiation in the histological sections. Photographic images were taken at 40×. Scale bars are 0.05 mm. The results are set forth in FIG. 1.
  • In reviewing histological sections, it is the basal layer where cellular proliferation takes place. As these newly proliferated cells are pushed to the epidermal layer they differentiate. In healthy skin the basal and epidermal layers must both show an appropriate mix of proliferation and differentiation that should be balanced. Cellular proliferation in the basal layer often decreases with age. As a result, cellular proliferation and differentiation in skin tends to diminish with age. Skin “lasts longer” and it often shows in the visual appearance of skin. In order for skin to appear most youthful and healthy skin renewal should be at the same or similar level that is found in young people.
  • The untreated control H&E and Ki-67 Caspase stained sections shows a basal to epidermal ratio of about 50:50. The basal skin layer shows cellular proliferation. The upper, epidermal layer is somewhat disrupted, but shows that cellular differentiation has occurred.
  • Skin sections treated with Test Formula show an increased basal layer that indicates that such treatment caused increased cellular proliferation in the basal layer. The epidermal layer is decreased in thickness compared to the untreated control, showing that the Test Formula appears to have somewhat of an inhibitory effect on the epidermal, differentiating, skin layer.
  • Skin sections treated with the watery lotion of Example 2 (“WL”) shows that the epidermal layer increases significantly, and the basal layer decreases. This indicates that watery lotion appears to promote cellular differentiation in the epidermal layer, and has somewhat of an inhibitory effect on cellular proliferation in the basal layer.
  • Skin sections treated with the combination of watery lotion+Test Formula show an even mix of basal and epidermal skin layers with good integrity. The sequential or layered application of the two products promotes balanced cellular proliferation in the basal layer and cellular differentiation in the epidermal layer. Most unexpectedly, the inhibitory effect of the Test Formula on cellular differentiation and the inhibitory effect of watery lotion on cellular proliferation appears to be negated with the sequential combination of the two products. Both the basal and epidermal layers are compact, adherent, and histologically show a cohesive barrier.
  • FIG. 2 shows skin sections marked for the presence of filaggrin, which is another marker for cellular differentiation.
  • The skin section showing untreated control demonstrates a differentiated, but somewhat disrupted epidermal layer.
  • Skin section “Test Formula” shows that the application of the Test Formula reduces the differentiated layer in the skin, thus apparently having a slightly inhibitory effect on cellular differentiation.
  • The skin section “WL” shows an increased epidermal layer demonstrating that the watery lotion does increase cellular differentiation in the basal layer.
  • The skin section “Test Formula+WL” shows that the sequential or combined application of Test Formula and WL shows more than an additive effect in increasing cellular differentiation in the epidermal layer in spite of the fact that one of the products (Test Formula) is shown to have an inhibitory effect on cellular differentiation in the basal layer.
  • Example 3
  • The composition and method of the invention was further tested to demonstrate increased water retention in skin using the product combination of the invention.
  • EFT-300 skin models were treated apically with samples alone or layered at day 0 and basal with 3 ml Media in a 6 well plate and incubated at 37° C. Samples were untreated control, Test Formula from Example 2 and Watery lotion formula of Example 1 (“WL”).
  • After 24 hours the skins were placed in a MatTek permeation device and treated apically with 200 μl of 100 ppm fluorescein in phosphate buffered saline. After 24 hours of fluorescein penetration skins were washed in PBS, weighed wet, then dried for 24 hours and re-weighed. Data was analyzed using one way analysis of variance (ANOVA) and significant means were tested using a Dunnet's multiple comparison post test using GraphPad Instat software. The results are set forth in FIG. 3, and show that skin samples treated with the combination of watery lotion of Example 1 and the Test Formula of Example 2 exhibit substantially improved water content retention in skin when compared to control and each product used separately.
  • While the invention has been described in connection with the preferred embodiment, it is not intended to limit the scope of the invention to the particular form set forth but, on the contrary, it is intended to cover such alternatives, modifications, and equivalents as may be included within the spirit and scope of the invention as defined by the appended claims.

Claims (18)

We claim:
1. A watery lotion composition for topical application to skin comprising at least one extract from the fermentation of the microorganism Bifidobacterium, at least one extract from the fermentation of the microorganism Lactobacillus, and mineral water having at least 250 ppm of total mineral dissolved solids.
2. The composition of claim 1 wherein the extract from the fermentation of the microorganism Bifidobacterium is Bifida ferment extract, Bifida ferment lysate, Bifida ferment filtrate, or mixtures thereof.
3. The composition of claim 1 wherein the extract from the fermentation of Bifidobacterium is present at 0.01-10% of the composition.
4. The composition of claim 1 wherein the extract from the fermentation of Lactobacillus is present at 0.001-10% of the composition.
5. The composition of claim 1 wherein the extract from the fermentation of Lactobacillus is a ferment extract, ferment lysate, or ferment filtrate.
6. The composition of claim 1 wherein the extract from the fermentation of Lactobacillus is from one or more of the species plantarum, casei, or crispatus.
7. The composition of claim 1 wherein the mineral water has a pH ranging from 2.5 to 4.3, and a specific gravity of 1.0 to 1.03.
8. The composition of claim 1 wherein the watery lotion comprises from 80-99% water.
9. A method for improving the efficacy of a watery lotion and/or second skin care product by layering the watery lotion and second skin care product wherein the watery lotion comprises at least one extract from the fermentation of a microorganism from the Lactobacillus or Bifidobacterium genus and the second skin care product comprises at least one extract from the fermentation of Lactobacillus or Bifidobacterium genus.
10. The method of claim 9 wherein the efficacy that is improved is water retention in skin.
11. The method of claim 9 wherein the efficacy that is improved is balanced skin renewal.
12. The method of claim 11 wherein the balanced skin renewal is shown by skin having basal and epidermal layers showing a ratio of 30-70% basal cell layer and 30-70% epidermal layer.
13. The method of claim 11 wherein the balanced skin renewal is show by skin having basal and epidermal layers showing a ratio of 40-60% basal layer and 60-40% of differentiated layer.
14. The method of claim 11 wherein the balanced skin renewal is shown by skin having about 50% basal layer and about 50% epidermal layer.
15. The method of claim 9 where the watery lotion comprises:
20-99% water,
0.1-5% one or more surfactants selected from alkylene glycols such as ethylene or propylene glycols; alkoxylated glucose, alkoxylated alcohols, glyceryl esters; glyceryl ethers, or mixtures thereof,
0.1-3% extract from probiotic microorganisms selected from Lactobacillus genus, Bifidobacterium genus, or mixtures thereof,
0.1-10% of humectants selected from polyhydric alcohols, alkylene glycols or glycerin, butylene glycol, hexylene glycol, or mixtures thereof.
16. The method of claim 15 wherein the skin care product comprises:
20-99% water,
0.1-5% one or more surfactants selected from PEG-60, PEG-75, PPG-5-Ceteth-20, Methyl gluceth-20, Bis-PEG-18 methyl ether dimethyl silane, Glycereth-26, Oleth-3 phosphate, Oleth-3, Oleth-5, Choleth-24, Ceteth-24, PEG-20 methyl glucosesesquiisostearate, and mixtures thereof;
0.1-3% extract from probiotic microorganisms selected from Lactobacillus genus, Bifidobacterium genus in the form of a ferment or ferment lysate, or mixtures thereof,
0.1-10% of humectants selected from polyhydric alcohols, alkylene glycols or glycerin, butylene glycol, hexylene glycol, propanediol, or mixtures thereof.
17. The method of claim 15 wherein the skin care product comprises:
20-99% water,
0.1-5% one or more surfactants selected from PEG-60, PEG-75, PPG-5-Ceteth-20, Methyl gluceth-20, Bis-PEG-18 methyl ether dimethyl silane, Glycereth-26, Oleth-3 phosphate, Oleth-3, Oleth-5, Choleth-24, Ceteth-24, PEG-20 methyl glucosesesquiisostearate, and mixtures thereof;
0.1-3% extract from probiotic microorganisms selected from Lactobacillus genus, Bifidobacterium genus in the form of a ferment or ferment lysate, or mixtures thereof,
0.1-10% of humectants selected from polyhydric alcohols, alkylene glycols or glycerin, butylene glycol, hexylene glycol, propanediol, or mixtures thereof.
18. The method of claim 9 wherein the watery lotion comprises:
80 to 99.9% by weight of water; and
at least one extract from the fermentation of the microorganism Bifidobacterium,
at least one extract from the fermentation of the microorganism Lactobacillus, and mineral water having at least 250 ppm of total mineral dissolved solids.
US14/497,711 2013-09-30 2014-09-26 Watery Lotion Skin Care Compositions And Methods Abandoned US20150093462A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US14/497,711 US20150093462A1 (en) 2013-09-30 2014-09-26 Watery Lotion Skin Care Compositions And Methods
US16/711,675 US11369564B2 (en) 2013-09-30 2019-12-12 Watery lotion skin care compositions and methods

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361884599P 2013-09-30 2013-09-30
US14/497,711 US20150093462A1 (en) 2013-09-30 2014-09-26 Watery Lotion Skin Care Compositions And Methods

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US16/711,675 Division US11369564B2 (en) 2013-09-30 2019-12-12 Watery lotion skin care compositions and methods

Publications (1)

Publication Number Publication Date
US20150093462A1 true US20150093462A1 (en) 2015-04-02

Family

ID=52740401

Family Applications (2)

Application Number Title Priority Date Filing Date
US14/497,711 Abandoned US20150093462A1 (en) 2013-09-30 2014-09-26 Watery Lotion Skin Care Compositions And Methods
US16/711,675 Active 2035-02-20 US11369564B2 (en) 2013-09-30 2019-12-12 Watery lotion skin care compositions and methods

Family Applications After (1)

Application Number Title Priority Date Filing Date
US16/711,675 Active 2035-02-20 US11369564B2 (en) 2013-09-30 2019-12-12 Watery lotion skin care compositions and methods

Country Status (8)

Country Link
US (2) US20150093462A1 (en)
EP (1) EP3052076B1 (en)
JP (1) JP6446037B2 (en)
KR (1) KR102001721B1 (en)
AU (1) AU2014324694B2 (en)
CA (1) CA2923236C (en)
ES (1) ES2864716T3 (en)
WO (1) WO2015048511A1 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101775122B1 (en) * 2016-02-26 2017-09-05 (주)진셀팜 Composition for improving skin conditions and preventing or treating proliferative skin diseases containing fermentation broth of yeast lysate mixture
US20170281694A1 (en) * 2016-03-31 2017-10-05 Gojo Industries, Inc. Topical cleansing composition with prebiotic/probiotic additive
WO2017173241A1 (en) * 2016-03-31 2017-10-05 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
US20170368109A1 (en) * 2016-06-28 2017-12-28 Animal Cell Therapies Inc. Probiotic Fermentation Products
WO2018098160A1 (en) * 2016-11-23 2018-05-31 Gojo Industries, Inc. Topical cleansing composition with prebiotic/probiotic additive
IT202000017188A1 (en) * 2020-07-15 2020-10-15 O F I Officina Farm Italiana S P A DERMATOLOGICAL COMPOSITION FOR REBALANCING THE SKIN, TO INCREASE IRMHYDRATION AND ELASTICITY AND TO REDUCE DISCOLORATION
US10806769B2 (en) 2016-03-31 2020-10-20 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
US20200368146A1 (en) * 2019-05-22 2020-11-26 Mary Ahern Method of cosmetic preservation
FR3117340A1 (en) * 2020-12-15 2022-06-17 Basf Beauty Care Solutions France Sas Cosmetic, nutraceutical or dermatological use of a strain of Lactobacillus crispatus and/or of a composition comprising it
US11564879B2 (en) 2016-11-23 2023-01-31 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101832288B1 (en) 2015-11-23 2018-04-04 대봉엘에스 주식회사 Method of preparing green tea extract by using magma seawater, carbonated water, or bedrock water, and functional cosmetic composition comprising the same
KR101785968B1 (en) * 2017-04-19 2017-10-17 주식회사 인투바이오 Cosmetic composition for improving skin condition
JP7019308B2 (en) * 2017-05-17 2022-02-15 花王株式会社 Emulsifying cosmetics
PL236460B1 (en) * 2018-04-04 2021-01-25 Dabrowska Mas Elzbieta Probiotic composition containing the probiotic, detoxification component and caffeine
WO2020001747A1 (en) 2018-06-26 2020-01-02 Symrise Ag Lactobacillus plantarum for skin care
CN111617025B (en) * 2020-06-12 2021-01-29 广州市千邦化妆品有限公司 Fermentation product cosmetic for whitening, removing freckles and resisting saccharification
CN115607487B (en) * 2022-09-16 2023-09-26 佛山天韵化妆品科技有限公司 Skin brightening and anti-aging preparation and application thereof

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6106846A (en) * 1995-09-19 2000-08-22 Societe L'oreal S.A. Use of at least one thermal spring water from Vichy as a substance P antagonist
US20030049231A1 (en) * 1999-12-22 2003-03-13 Markus Baur Agent for the anti-adhesion of skin pathogenic flora
US20060171936A1 (en) * 2004-10-04 2006-08-03 L'oreal Cosmetic and/or dermatological composition for sensitive skin
US20090060962A1 (en) * 2007-09-04 2009-03-05 L'oreal Cosmetic use of bifidobacterium species lysate for the treatment of dryness
US20090068160A1 (en) * 2007-09-04 2009-03-12 L'oreal Use of a lysate of bifidobacterium species for treating sensitive skin
US20090068161A1 (en) * 2007-09-04 2009-03-12 L'oreal Use of a combination of hesperidin and of a microorganism for influencing the barrier function of the skin
US20100136662A1 (en) * 2001-02-06 2010-06-03 Nestec S.A. Endotoxin binding by lactic acid bacteria and bifidobacteria
US20110014248A1 (en) * 2008-07-29 2011-01-20 L'oreal Cosmetic use of microorganism(s) for the treatment of scalp disorders
US8193155B2 (en) * 2009-02-09 2012-06-05 Elc Management, Llc Method and compositions for treating skin
US20120294841A1 (en) * 2009-12-08 2012-11-22 Nestec S.A. Probiotic microorganisms as active agents against changes in the skin's microrelief
US20130129653A1 (en) * 2010-04-23 2013-05-23 L'oreal Cosmetic use of a lysate of bifidobacterium species for treating body odor

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100302504B1 (en) * 1998-12-12 2001-09-22 이세복 Fermented product using lactic acid bacteria and cosmetic composition
WO2005091933A2 (en) * 2004-03-04 2005-10-06 E-L Management Corporation Skin treatment method with lactobacillus extract
JP2008503563A (en) * 2004-06-23 2008-02-07 ロレアル Methods and compositions useful for the prevention and / or treatment of sensitive and / or dry skin
US8703161B2 (en) * 2007-08-13 2014-04-22 Elc Management, Llc Skin repair compositions comprising circadian gene activators and a synergistic combination of Sirt1 gene activators
US20090047309A1 (en) * 2007-08-13 2009-02-19 Maes Daniel H Cosmetic methods and compositions for repairing human skin
JP2009215325A (en) * 2009-07-03 2009-09-24 Tsujido Chemical Corp Skin preparation for external use
US20110280850A1 (en) * 2010-05-12 2011-11-17 Starr Elizabeth I Compositions Containing DNA Repair Enzyme And Anogeissus Extract
CN102078354B (en) * 2011-01-21 2012-08-22 吉林紫鑫药物研究有限公司 Medicine composition capable of improving immunity and preparation method thereof
KR101242442B1 (en) * 2011-06-21 2013-03-12 주식회사 마크로케어 Cosmetic Composition Comprising Extracts of Fermented Setaria italica
US20140242010A1 (en) * 2011-10-11 2014-08-28 Elc Management Llc Method And Compositions For Treating Skin
DE102011089581A1 (en) * 2011-12-22 2013-06-27 Henkel Ag & Co. Kgaa Two-phase facial cleanser with high eye and mucous membrane compatibility
CN103027231B (en) * 2013-01-01 2013-12-18 蒋常德 Compound probiotics fermented Chinese herbal medicine active health care liquid and preparation method thereof

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6106846A (en) * 1995-09-19 2000-08-22 Societe L'oreal S.A. Use of at least one thermal spring water from Vichy as a substance P antagonist
US20030049231A1 (en) * 1999-12-22 2003-03-13 Markus Baur Agent for the anti-adhesion of skin pathogenic flora
US20100136662A1 (en) * 2001-02-06 2010-06-03 Nestec S.A. Endotoxin binding by lactic acid bacteria and bifidobacteria
US20060171936A1 (en) * 2004-10-04 2006-08-03 L'oreal Cosmetic and/or dermatological composition for sensitive skin
US20090060962A1 (en) * 2007-09-04 2009-03-05 L'oreal Cosmetic use of bifidobacterium species lysate for the treatment of dryness
US20090068160A1 (en) * 2007-09-04 2009-03-12 L'oreal Use of a lysate of bifidobacterium species for treating sensitive skin
US20090068161A1 (en) * 2007-09-04 2009-03-12 L'oreal Use of a combination of hesperidin and of a microorganism for influencing the barrier function of the skin
US20110014248A1 (en) * 2008-07-29 2011-01-20 L'oreal Cosmetic use of microorganism(s) for the treatment of scalp disorders
US8193155B2 (en) * 2009-02-09 2012-06-05 Elc Management, Llc Method and compositions for treating skin
US20120294841A1 (en) * 2009-12-08 2012-11-22 Nestec S.A. Probiotic microorganisms as active agents against changes in the skin's microrelief
US20130129653A1 (en) * 2010-04-23 2013-05-23 L'oreal Cosmetic use of a lysate of bifidobacterium species for treating body odor

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Blanes-Mira et al. (2002) Intern. J. Cosmetic Science, 24, 303-310. *
Gueniche et al. (2009) Experimental Dermatology, 19, e1-e8. *
Ruiz et al. (2007) J. Cosmet. Sci. 58, 157-171. *
Seite (2013) Clinical, Cosmetic and Investigational Dermatology, 6: 23-28. *

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101775122B1 (en) * 2016-02-26 2017-09-05 (주)진셀팜 Composition for improving skin conditions and preventing or treating proliferative skin diseases containing fermentation broth of yeast lysate mixture
US10874700B2 (en) 2016-03-31 2020-12-29 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
WO2017173242A1 (en) * 2016-03-31 2017-10-05 Gojo Industries, Inc. Topical cleansing composition with prebiotic/probiotic additive
US11633451B2 (en) 2016-03-31 2023-04-25 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
US10806769B2 (en) 2016-03-31 2020-10-20 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
WO2017173241A1 (en) * 2016-03-31 2017-10-05 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
US20170281694A1 (en) * 2016-03-31 2017-10-05 Gojo Industries, Inc. Topical cleansing composition with prebiotic/probiotic additive
US20170368109A1 (en) * 2016-06-28 2017-12-28 Animal Cell Therapies Inc. Probiotic Fermentation Products
US11564879B2 (en) 2016-11-23 2023-01-31 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
WO2018098160A1 (en) * 2016-11-23 2018-05-31 Gojo Industries, Inc. Topical cleansing composition with prebiotic/probiotic additive
US20200368146A1 (en) * 2019-05-22 2020-11-26 Mary Ahern Method of cosmetic preservation
WO2022013897A1 (en) * 2020-07-15 2022-01-20 O.F.I. Officina Farmaceutica Italiana S.P.A. Dermatological composition for rebalancing the skin, for increasing its hydration and elasticity and for reducing dynamic disorders
IT202000017188A1 (en) * 2020-07-15 2020-10-15 O F I Officina Farm Italiana S P A DERMATOLOGICAL COMPOSITION FOR REBALANCING THE SKIN, TO INCREASE IRMHYDRATION AND ELASTICITY AND TO REDUCE DISCOLORATION
FR3117340A1 (en) * 2020-12-15 2022-06-17 Basf Beauty Care Solutions France Sas Cosmetic, nutraceutical or dermatological use of a strain of Lactobacillus crispatus and/or of a composition comprising it
WO2022129775A1 (en) * 2020-12-15 2022-06-23 Basf Beauty Care Solutions France Sas Cosmetic, nutraceutical or dermatological use of a lactobacillus crispatus strain and/or of a composition comprising same

Also Published As

Publication number Publication date
AU2014324694A1 (en) 2016-04-14
ES2864716T3 (en) 2021-10-14
CA2923236A1 (en) 2015-04-02
US11369564B2 (en) 2022-06-28
KR20160046896A (en) 2016-04-29
US20200113815A1 (en) 2020-04-16
AU2014324694B2 (en) 2017-06-29
JP6446037B2 (en) 2018-12-26
JP2016531875A (en) 2016-10-13
WO2015048511A1 (en) 2015-04-02
EP3052076A4 (en) 2017-03-22
CA2923236C (en) 2019-06-04
KR102001721B1 (en) 2019-07-18
EP3052076A1 (en) 2016-08-10
EP3052076B1 (en) 2021-03-03

Similar Documents

Publication Publication Date Title
US11369564B2 (en) Watery lotion skin care compositions and methods
US20170354629A1 (en) Method And Compositions For Treating Skin
US20160120781A1 (en) Skincare formulations and regimens
CN101528194B (en) Marine extracts and biofermentations for use in cosmetics
EP2897582B1 (en) Compositions for improving selective catabolysis in cells of keratin surfaces
KR101972071B1 (en) Cosmetic composition for improving skin tone or skin elasticity
KR20190122269A (en) Topical skin care formulations comprising plant extracts
EP2941241B1 (en) Method and compositions for improving selective catabolysis and viability in cells of keratin surfaces
JP6982076B2 (en) Cosmetic composition
CN111971022B (en) Use of a composition for preventing or reducing the appearance of signs of inflammation
CN109330954B (en) Whitening skin brightening lotion, preparation method thereof and tyrosinase inhibitor
US11224627B2 (en) Method for culturing cells of Acrochaetium moniliforme red algae, method for obtaining an extract of the biomass thereof, and use of same in cosmetics
US11357719B2 (en) Method for obtaining a diglycoside-enriched Armeria maritima extract, and use thereof in cosmetics
CN113041177A (en) Collagenase inhibitor, eye essence containing the same and preparation method thereof
KR102397975B1 (en) External composition for moisturizing of skin comprising kirenol
US20210382039A1 (en) Method for assessing the ability of a substance or of a composition to prevent, slow or eliminate the signs of ageing of the skin or of the lips

Legal Events

Date Code Title Description
STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION